151 related articles for article (PubMed ID: 38668048)
1. Determining the Need for Metastatic Staging in Patients with Bilateral Breast Cancers.
Alcantara VS; Chan SMZ; Wong FY; Allen JC; Lim GH
Curr Oncol; 2024 Apr; 31(4):1936-1946. PubMed ID: 38668048
[No Abstract] [Full Text] [Related]
2. Is Metastatic Staging Needed for All Patients with Synchronous Bilateral Breast Cancers?
Lim GH; Hoo JX; Shin YC; Choo RZT; Wong FY; Allen JC
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201445
[TBL] [Abstract][Full Text] [Related]
3. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Skip Metastases: Frequency, Associated Tumor Characteristics, and Role of Staging Nodal Ultrasound in Detection.
Chung HL; Sun J; Leung JWT
AJR Am J Roentgenol; 2021 Oct; 217(4):835-844. PubMed ID: 32997506
[No Abstract] [Full Text] [Related]
5. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003-2017).
Pan B; Xu Y; Zhou Y; Yao R; Zhou X; Xu Y; Ren X; Xiao M; Zhu Q; Kong L; Mao F; Lin Y; Zhang X; Shen S; Sun Q
Breast Cancer Res Treat; 2022 Nov; 196(2):409-422. PubMed ID: 36166112
[TBL] [Abstract][Full Text] [Related]
7. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes.
Mruthyunjayappa S; Zhang K; Zhang L; Eltoum IA; Siegal GP; Wei S
Hum Pathol; 2019 Oct; 92():1-9. PubMed ID: 31351153
[TBL] [Abstract][Full Text] [Related]
8. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.
Sopik V; Iqbal J; Sun P; Narod SA
Breast Cancer Res Treat; 2016 Jul; 158(2):385-93. PubMed ID: 27383477
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
10. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M
Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614
[TBL] [Abstract][Full Text] [Related]
11. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
[TBL] [Abstract][Full Text] [Related]
12. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study.
Keymeulen KBIM; Geurts SME; Kooreman LFS; Duijm LEM; Engelen S; Vanwetswinkel S; Luiten E; Siesling S; Voogd AC; Tjan-Heijnen VCG
Eur Radiol; 2023 Mar; 33(3):2209-2217. PubMed ID: 36180645
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of synchronous and metachronous bilateral breast cancer.
Kollias J; Ellis IO; Elston CW; Blamey RW
World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
[TBL] [Abstract][Full Text] [Related]
15. [Bilateral breast carcinoma. 12 years' experience].
Maculotti L; Gandini F; Pradella P
Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
[TBL] [Abstract][Full Text] [Related]
16. Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer?
Senofsky GM; Wanebo HJ; Wilhelm MC; Pope TL; Fechner RE; Broaddus W; Kaiser DL
Cancer; 1986 Feb; 57(3):597-602. PubMed ID: 3942996
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
19. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
20. A case-control study of unilateral and bilateral breast carcinoma patients.
Newman LA; Sahin AA; Cunningham JE; Bondy ML; Mirza NQ; Vlastos GS; Whitman GJ; Brown H; Buchholz TA; Lee MH; Singletary SE
Cancer; 2001 May; 91(10):1845-53. PubMed ID: 11346865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
